Endothelin system mRNA variation in the heart of Zucker rats: Evaluation of a possible balance with natriuretic peptides

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 24, Issue 11, 2014, Pages 1166-1173

  Cabiati, M ^a   Belcastro, E ^a   Caselli, C ^a   Prescimone, T ^a   D'Amico, A ^b   Guzzardi, M A ^a   Iozzo, P ^a   Giannessi, D ^a   Del Ry, S ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b SCUOLA SUPERIORE SANT ANNA   (Italy)

Author keywords

Cardiac tissue; Endothelin system; MRNA expression; Natriuretic peptides system; Zucker rat model

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CHOLESTEROL; ENDOTHELIN; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN CONVERTING ENZYME; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INTERLEUKIN 6; MESSENGER RNA; NATRIURETIC PEPTIDE RECEPTOR A; NATRIURETIC PEPTIDE RECEPTOR B; NATRIURETIC PEPTIDE RECEPTOR C; TATA BINDING PROTEIN; TRANSCRIPTOME; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC VARIABILITY; HYPERGLYCEMIA; IMMUNOASSAY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 84911991689     PISSN: 09394753     EISSN: 15903729     Source Type: Journal    
DOI: 10.1016/j.numecd.2014.05.008     Document Type: Article

References (28)

1. James P.T. Obesity: the worldwide epidemic. Clin Dermatol 2004, 22:276-280.
2. Poirier P., Eckel R.H. Obesity and cardiovascular disease. Curr Atheroscler Rep 2002, 4:448-453.
3. Lafontan M., Moro C., Berlan M., Crampes F., Sengenes C., Galitzky J. Control of lipolysis by natriuretic peptides and cyclic GMP. Trends Endocrinol Metab 2008, 19:130-137.
4. Licata G., Volpe M., Scaglione R., Rubattu S. Salt-regulating hormones in young normotensive obese subjects. Effects of saline load. Hypertension 1994, 23:I20-I24.
5. Sarzani R., Salvi F., Dessí-Fulgheri P., Rappelli A. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, hypertension: an integrated view in humans. J Hypertens 2008, 26:831-843.
6. Cabiati M., Raucci S., Liistro T., Belcastro E., Prescimone T., Caselli C., et al. Impact of obesity on the expression profile of natriuretic peptide system in a rat experimental model. PLoS ONE 2013, 8:e72959.
7. Mather K.J., Mirzamohammadi B., Lteif A., Steinberg H.O., Baron A.D. Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes. Diabetes 2002, 51:3517-3523.
8. Touyz R.M., Schiffrin E.L. Role of endothelin in human hypertension. Can J Physiol Pharmacol 2003, 81:533-541.
9. Cardillo C., Campia U., Iantorno M., Panza J.A. Enhanced vascular activity of endogenous endothelin-1 in obese hypertensive patients. Hypertension 2004, 43:36-40.
10. Davenport A.P. International Union of Pharmacology. XXIX. Update on endothelin receptor nomenclature. Pharmacol Rev 2002, 54:219-226.
11. Molenaar P., O'Reilly G., Sharkey A., Kuc R.E., Harding D.P., Plumpton C., et al. Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circ Res 1993, 72:526-538.
12. Fukuroda T., Fujikawa T., Ozaki S., Ishikawa K., Yano M., Nishikibe M. Clearance of circulating endothelin-1 by ETB receptors in rats. Biochem Biophys Res Comm 1994, 199:1461-1465.
13. Traupe T., D'Uscio L.V., Muenter K., Morawietz H., Vetter W., Barton M. Effects of obesity on endothelium-dependent reactivity during acute nitric oxide synthase inhibition: modulatory role of endothelin. Clin Sci Lond 2002, 103:13S-15S.
14. Wu S.Q., Hopfner R.L., McNeill J.R., Wilson T.W., Gopalakrishnan V. Altered paracrine effect of endothelin in blood vessels of the hyperinsulinemic, insulin resistant obese Zucker rat. Cardiovas Res 2000, 45:994-1000.
15. Guiducci L., Liistro T., Burchielli S., Panetta D., Bonora D., Di Cecco P., et al. Contribution of organ blood flow, intrinsic tissue clearance and glycemia to the regulation of glucose use in obese and type 2 diabetic rats: a PET study. Nutr Metab Cardiovasc Dis 2011, 21:726-732.
16. Del Ry S., Cabiati M., Lionetti V., Emdin M., Recchia F.A., Giannessi D. Expression of C-type natriuretic peptide and of its receptor NPR-B in normal and failing heart. Peptides 2008, 29:2208-2215.
17. Del Ry S., Cabiati M., Lionetti V., Simioniuc A., Caselli C., Prescimone T., et al. Asymmetrical myocardial expression of natriuretic peptides in pacing-induced heart failure. Peptides 2009, 30:1710-1713.
18. Cabiati M., Raucci S., Caselli C., Guzzardi M.A., D'Amico A., Prescimone T., et al. Tissue-specific selection of stable reference genes for real-time PCR normalization in an obese rat model. J Mol Endocrinol 2012, 48:251-260.
19. Lowry O.H., Rosebrough A., Farr A., Randall R.J. Protein measurement with the folin phenol reagent. JBiol Chem 1951, 193:265-267.
20. Bustin S.A., Benes V., Garson J.A., Hellemans J., Huggett J., Kubista M., et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009, 55:611-622.
21. Stapleton P.A., James M.E., Goodwill A.G., Frisbee J.C. Obesity and vascular dysfunction. Pathophysiology 2008, 15:79-89.
22. Vykoukal D., Davies M.G. Vascular biology of metabolic syndrome. J Vasc Surg 2011, 54:819-831.
23. Leoncini G., Ratto E., Viazzi F., Vaccaro V., Parodi D., Parodi A., et al. Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients. J Int Med 2005, 257:454-460.
24. Weil B.R., Westby C.M., Van Guilder G.P., Greiner J.J., Stauffer B.L., DeSouza C.A. Enhanced endothelin-1 system activity with overweight and obesity. Am J Physiol Heart Circ Physiol 2011, 301:H689-H695.
25. Savoia C., Volpe M., Alonzo A., Rossi C., Rubattu S. Natriuretic peptides and cardiovascular damage in the metabolic syndrome: molecular mechanism and clinical implications. Clin Sci 2010, 118:231-240.
26. Yoshimoto T., Naruse M., Naruse K., Arai K., Imaki T., Tanabe A., et al. Vascular action of circulating and local natriuretic peptide system is potentiated in obese/hyperglicemic and hypertensive rats. Endocrinology 1996, 137:5552-5557.
27. Hopfner R.L., Gopalakrishnan V. Endothelin: emerging role in diabetic vascular complications. Diabetologia 1999, 24:1383-1394.
28. Strohacker K., McFarlin B.K. Influence of obesity, physical inactivity, and weight cycling on chronic inflammation. Front Biosci (Elite Ed) 2010, 2:98-104.